Fig. 9

Significantly enriched metabolic pathways in different sensitivity groups during NCRT. (A) Metabolic pathways enriched in RA-S vs. RB-S. (B) Metabolic pathways enriched in RA-NS vs. RB-NS. (C) Metabolic pathways enriched in RB-S vs. RB-NS. (D) Metabolic pathways enriched in RA-S vs. RA-NS